1. Home
  2. LGVN vs BTBD Comparison

LGVN vs BTBD Comparison

Compare LGVN & BTBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$0.83

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Logo BT Brands Inc.

BTBD

BT Brands Inc.

HOLD

Current Price

$1.06

Market Cap

7.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGVN
BTBD
Founded
2014
1987
Country
United States
United States
Employees
N/A
188
Industry
Medicinal Chemicals and Botanical Products
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
25.9M
7.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
LGVN
BTBD
Price
$0.83
$1.06
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
208.3K
43.6K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
50.76
N/A
EPS
N/A
N/A
Revenue
$709,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$1.03
52 Week High
$1.80
$5.59

Technical Indicators

Market Signals
Indicator
LGVN
BTBD
Relative Strength Index (RSI) 52.50 36.69
Support Level $0.73 $1.03
Resistance Level $0.84 $1.22
Average True Range (ATR) 0.05 0.07
MACD 0.01 0.01
Stochastic Oscillator 65.72 17.50

Price Performance

Historical Comparison
LGVN
BTBD

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

About BTBD BT Brands Inc.

BT Brands Inc operates and owns a fast-food restaurant called Burger Time. Its offerings include a variety of burgers and other affordable items, including sides and soft drinks. The company owns and operates Keegan's Seafood Grille (Keegan's), a dine-in restaurant located in Florida; Pie In The Sky Coffee and Bakery (PIE), located in Massachusetts; and Schnitzel Haus, a German-themed restaurant located in Florida. The company's revenues are derived from the sale of food and beverages at its restaurants.

Share on Social Networks: